Ignite Creation Date:
2025-12-24 @ 7:10 PM
Ignite Modification Date:
2026-05-03 @ 6:22 PM
Study NCT ID:
NCT02981303
Status:
COMPLETED
Last Update Posted:
2024-07-09
First Post:
2016-11-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer
Sponsor:
HiberCell, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BT-CL-PGG-MEL/BCA-1621/MK3475
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |